摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-[2-[[3-[2-[2-[2-[(1S,2R)-2-hydroxy-1-[(3S)-1,3,4-trihydroxybutan-2-yl]oxypropoxy]ethoxy]ethoxy]ethylamino]-3-oxopropoxy]methyl]-2-methyl-3-[3-oxo-3-[2-[2-[2-[(2S,3R,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethoxy]ethylamino]propoxy]propoxy]-N-[2-[2-[2-[(2S,3R,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethoxy]ethyl]propanamide

中文名称
——
中文别名
——
英文名称
3-[2-[[3-[2-[2-[2-[(1S,2R)-2-hydroxy-1-[(3S)-1,3,4-trihydroxybutan-2-yl]oxypropoxy]ethoxy]ethoxy]ethylamino]-3-oxopropoxy]methyl]-2-methyl-3-[3-oxo-3-[2-[2-[2-[(2S,3R,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethoxy]ethylamino]propoxy]propoxy]-N-[2-[2-[2-[(2S,3R,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethoxy]ethyl]propanamide
英文别名
——
3-[2-[[3-[2-[2-[2-[(1S,2R)-2-hydroxy-1-[(3S)-1,3,4-trihydroxybutan-2-yl]oxypropoxy]ethoxy]ethoxy]ethylamino]-3-oxopropoxy]methyl]-2-methyl-3-[3-oxo-3-[2-[2-[2-[(2S,3R,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethoxy]ethylamino]propoxy]propoxy]-N-[2-[2-[2-[(2S,3R,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethoxy]ethoxy]ethyl]propanamide化学式
CAS
——
化学式
C51H97N3O30
mdl
——
分子量
1232.3
InChiKey
PSCWMKCUNUSGSV-KICLJTGZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -9.6
  • 重原子数:
    84
  • 可旋转键数:
    53
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.94
  • 拓扑面积:
    469
  • 氢给体数:
    15
  • 氢受体数:
    30

文献信息

  • COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF TMPRSS6 GENE
    申请人:Bumcrot David
    公开号:US20140194489A1
    公开(公告)日:2014-07-10
    The invention relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the TMPRSS6 gene, and methods of using such dsRNA compositions to inhibit expression of TMPRSS6.
  • SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
    申请人:ALNYLAM PHARMACEUTICALS, INC.
    公开号:US20140350071A1
    公开(公告)日:2014-11-27
    The invention relates to RNAi agents, e.g., double-stranded RNAi agents, targeting the Serpina1 gene, and methods of using such RNAi agents to inhibit expression of Serpina1 and methods of treating subjects having a Serpina1 associated disease, such as a liver disorder.
  • Compositions and Methods for Inhibition of Expression of Apolipoprotein C-III (APOC3) Genes
    申请人:Alnylam Pharmaceuticals, Inc.
    公开号:US20160333342A1
    公开(公告)日:2016-11-17
    The invention relates to double-stranded ribonucleic acid (dsRNA) targeting an APOC3 gene, and methods of using the dsRNA to inhibit expression of APOC3.
  • US9175290B2
    申请人:——
    公开号:US9175290B2
    公开(公告)日:2015-11-03
查看更多